Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.

Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/A...

Full description

Bibliographic Details
Main Authors: James D Heffelfinger, Andrew C Voetsch, Glenn V Nakamura, Patrick S Sullivan, A D McNaghten, Laurence Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2656642?pdf=render
_version_ 1818510505593012224
author James D Heffelfinger
Andrew C Voetsch
Glenn V Nakamura
Patrick S Sullivan
A D McNaghten
Laurence Huang
author_facet James D Heffelfinger
Andrew C Voetsch
Glenn V Nakamura
Patrick S Sullivan
A D McNaghten
Laurence Huang
author_sort James D Heffelfinger
collection DOAJ
description Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >or=18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?" We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good" for >or=1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was <200 cells/microL (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed.Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP.
first_indexed 2024-12-10T23:20:53Z
format Article
id doaj.art-4abedc1a12ae49b9adb2d228fb6f2aa4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T23:20:53Z
publishDate 2009-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4abedc1a12ae49b9adb2d228fb6f2aa42022-12-22T01:29:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0143e500210.1371/journal.pone.0005002Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.James D HeffelfingerAndrew C VoetschGlenn V NakamuraPatrick S SullivanA D McNaghtenLaurence HuangDespite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >or=18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?" We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good" for >or=1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was <200 cells/microL (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed.Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP.http://europepmc.org/articles/PMC2656642?pdf=render
spellingShingle James D Heffelfinger
Andrew C Voetsch
Glenn V Nakamura
Patrick S Sullivan
A D McNaghten
Laurence Huang
Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
PLoS ONE
title Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
title_full Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
title_fullStr Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
title_full_unstemmed Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
title_short Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
title_sort nonadherence to primary prophylaxis against pneumocystis jirovecii pneumonia
url http://europepmc.org/articles/PMC2656642?pdf=render
work_keys_str_mv AT jamesdheffelfinger nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia
AT andrewcvoetsch nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia
AT glennvnakamura nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia
AT patrickssullivan nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia
AT admcnaghten nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia
AT laurencehuang nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia